Shanghai fever, a fatal enteric illness, in an adult patient with neutropenia caused by treatment-related myelodysplastic syndrome: a case report

Abstract Background Shanghai fever is a rare community-acquired enteric illness with sepsis caused by Pseudomonas aeruginosa. Cases of Shanghai fever in pediatric patients have been reported; however, to the best of our knowledge, there are no reports of adult cases. Case presentation A 65-year-old...

Full description

Bibliographic Details
Published in:	Surgical Case Reports
Main Authors:	Taichi Horino, Tatsunori Miyata, Mitsuhiro Inoue, Kosuke Ono, Asuka Ono, Yoshiyuki Tagayasu, Daichi Nomoto, Takao Mizumoto, Tatsuo Kubota, Nobutomo Miyanari, Hideo Baba
Format:	Article
Language:	English
Published:	Japan Surgical Society 2022-04-01
Subjects:	Shanghai fever Pseudomonas aeruginosa Bowel perforation Treatment-related MDS
Online Access:	https://doi.org/10.1186/s40792-022-01426-5

Similar Items

DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES
by: Prof. Giuseppe Leone, et al.
Published: (2022-04-01)

Current State and Challenges in Development of Targeted Therapies in Myelodysplastic Syndromes (MDS)
by: Michele Stanchina, et al.
Published: (2021-04-01)

Surgical resection of a ruptured transverse pancreatic artery aneurysm
by: Toru Takematsu, et al.
Published: (2021-02-01)

Advances and challenges in the treatment of myelodysplastic syndromes
by: Rohit Thalla, et al.
Published: (2025-06-01)

Laparoscopic removal of an ingested fish bone that penetrated the stomach and was embedded in the pancreas: a case report
by: Kosuke Mima, et al.
Published: (2018-12-01)

Lower‐risk myelodysplastic syndromes: Current treatment options for anemia
by: Mathieu Meunier, et al.
Published: (2022-11-01)

CLINICO-PATHOLOGICAL SPECTRUM AND NOVEL KARYOTYPIC FINDINGS IN MYELODYSPLASTIC SYNDROME: EXPERIENCE OF TERTIARY CARE CENTRE IN INDIA.
by: Ruchi Gupta, et al.
Published: (2017-08-01)

The Genomics of Myelodysplastic Syndromes: Origins of Disease Evolution, Biological Pathways, and Prognostic Implications
by: Hassan Awada, et al.
Published: (2020-11-01)

A rare case of myelodysplastic syndrome with refractory thrombocytopenia
by: Waqas Jehangir, et al.
Published: (2015-09-01)

Immune checkpoint gene VSIR predicts patient prognosis in acute myeloid leukemia and myelodysplastic syndromes
by: Kevin Yao, et al.
Published: (2023-03-01)

CLINICAL AND CYTOGENETIC PROFILE IN PATIENTS WITH MYELODYSPLASTIC SYNDROME
by: Muneshwar Kumar, et al.
Published: (2019-06-01)

A Child with Psoriasis, Hypogammaglobulinemia, and Monosomy 7-Positive Myelodysplastic Syndrome
by: Namik Özbek, et al.
Published: (2015-02-01)

Single-cell transcriptome sequencing reveals the mechanism of Realgar improvement on erythropoiesis in mice with myelodysplastic syndrome
by: Hao Xu, et al.
Published: (2025-04-01)

The Role of BCL-2 Expression in Patients with Myelodysplastic Neoplasms
by: Bartłomiej Kuszczak, et al.
Published: (2025-05-01)

A fascia lata free flap in pelvic exenteration for Fournier gangrene due to advanced rectal cancer: a case report
by: Hiroshi Sawayama, et al.
Published: (2017-05-01)

Immune checkpoints represent a promising breakthrough in targeted therapy and prognosis of myelodysplastic syndrome
by: Xinyu Guo, et al.
Published: (2023-09-01)

Azacytidine failure revisited: an appraisal based on real life data from the MDS registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS).
by: IOANNIS KOTSIANIDIS
Published: (2019-06-01)

Successful treatment of low‐risk myelodysplastic syndrome‐related anemia in patients with chronic kidney disease with daprodustat: A report of two cases
by: Hiroyoshi Kunimoto, et al.
Published: (2024-12-01)

Emerging Insights into Molecular Mechanisms of Inflammation in Myelodysplastic Syndromes
by: Veronica Vallelonga, et al.
Published: (2023-09-01)

KI-67 AS A PROGNOSTIC FACTOR OF MYELODYSPLASTIC SYNDROME
by: G.S. Starodub, et al.
Published: (2016-04-01)

Aberrantly elevated suprabasin in the bone marrow as a candidate biomarker of advanced disease state in myelodysplastic syndromes
by: Miroslav Pribyl, et al.
Published: (2020-10-01)

The immunoregulatory role of monocytes and thrombomodulin in myelodysplastic neoplasms
by: Luca L. G. Janssen, et al.
Published: (2024-07-01)

Targeting CD47/SIRPα in Acute Myeloid Leukemia and Myelodysplastic Syndrome: Preclinical and Clinical Developments of Magrolimab
by: Fadi Haddad, et al.
Published: (2021-05-01)

Acute myeloid leukemia cells and MSC-derived exosomes inhibiting transformation in myelodysplastic syndrome
by: Xiaoli Liu, et al.
Published: (2023-06-01)

657del5 mutation of the NBS1 gene in myelodysplastic syndrome
by: Bunjevacki Vera, et al.
Published: (2014-01-01)

Myelodysplastic Neoplasms (MDS): The Current and Future Treatment Landscape
by: Daniel Karel, et al.
Published: (2024-04-01)

Research progress on classification and prognostic stratification of myelodysplastic syndrome
by: WU Duoer, CHANG Chunkang
Published: (2023-10-01)

REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
by: Emmanuel Gyan, et al.
Published: (2015-02-01)

Clinical and Molecular Characteristics of Megakaryocytes in Myelodysplastic Syndrome
by: Fangxiu Luo, et al.
Published: (2024-06-01)

The role of genetic factors in pediatric myelodysplastic syndromes with different outcomes
by: Ying Li, et al.
Published: (2024-01-01)

Utility of a Single-Tube, Six-Color Flow Cytometry Panel for the Diagnosis of Myelodysplastic Syndrome: Experience of a Tertiary Care Centre in India
by: R. Gupta, et al.
Published: (2018-01-01)

The Evolving Landscape of Myelodysplastic Syndrome Prognostication
by: Jacob Shreve, et al.
Published: (2020-04-01)

LEP promoter methylation in the initiation and progression of clonal cytopenia of undetermined significance and myelodysplastic syndrome
by: Katja Kaastrup, et al.
Published: (2023-05-01)

Hematologic improvements in a myelodysplastic syndromes with myelofibrosis (MDS-F) patient treated with azacitidine
by: Daisuke Okamura, et al.
Published: (2014-01-01)

The Impact of Microenvironment and Dysplasia Types on the Prognosis of Myelodysplastic Syndrome
by: Irem Guvendir Bakkaloglu, et al.
Published: (2024-12-01)

Clinical significance of prognostic nutritional index in myelodysplastic syndrome
by: Yue Chen, et al.
Published: (2023-12-01)

HAPLOIDENTICAL TRANSPLANT WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR ACUTE MYELOID LEUKAEMIA AND MYELODYSPLASTIC SYNDROMES PATIENTS: THE ROLE OF PREVIOUS LINES OF THERAPY.
by: Daniele Avenoso, et al.
Published: (2024-01-01)

Experiences and Support Needs of Caregivers of Patients with Higher-Risk Myelodysplastic Syndrome via Online Bulletin Board in the USA, Canada and UK
by: Pauline Frank, et al.
Published: (2023-12-01)

The role of the CLL-1 protein in disease monitoring in patients diagnosed with acute myeloid leukaemia and myelodysplastic syndrome
by: Ewa Dobak, et al.
Published: (2024-10-01)

Treatment of Vietnamese patients diagnosed with myelodysplastic neoplasms: Practical experience in a developing country
by: Quang Hao Nguyen, et al.
Published: (2025-01-01)